Literature DB >> 12960470

Apoptosis as a therapeutic target in acutely ischemic myocardium.

Shaila Garg1, Leo Hofstra, Chris Reutelingsperger, Jagat Narula.   

Abstract

In addition to necrosis, apoptosis makes a significant contribution to cell death following acute myocardial ischemia; apoptosis is particularly enhanced during reperfusion. Several studies are beginning to indicate that the cell death by apoptosis may be preventable. A boost in the research in this direction has been provided by noninvasive means of detection of apoptosis, such as that achieved by technetium-99m labeled Annexin-A5 scintigraphy. Various levels within the apoptotic cascade are being investigated as therapeutic targets. Caspase inhibitors, mitochondrial stabilizers, and Na+-H+ exchanger inhibitors reduce cell death by apoptosis and infarct size. Although most of the evidence at present is limited to the laboratory animals, this approach seems to hold a promise for the future.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960470     DOI: 10.1097/00001573-200309000-00009

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  10 in total

Review 1.  Noninvasive imaging of apoptosis in cardiovascular disease.

Authors:  Ethan Chauncey Korngold; Farouc Amin Jaffer; Ralph Weissleder; David Edwin Sosnovik
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

2.  Overexpression of the NHE1 isoform of the Na(+)/H (+) exchanger causes elevated apoptosis in isolated cardiomyocytes after hypoxia/reoxygenation challenge.

Authors:  Pratap Karki; Larry Fliegel
Journal:  Mol Cell Biochem       Date:  2009-12-01       Impact factor: 3.396

3.  The changes of technetium-99m-labeled annexin-V in delayed anesthetic preconditioning during myocardial ischemia/reperfusion.

Authors:  Hong Xie; Xia Liu; Chen Wang; Jiang Zhu; Chen Yang; Chunfeng Liu; Hong Liu; Xuemei Wu
Journal:  Mol Biol Rep       Date:  2013-11-06       Impact factor: 2.316

4.  Radiolabeled Duramycin: Promising Translational Imaging of Myocardial Apoptosis.

Authors:  Joseph C Wu; Xulei Qin; Evgenios Neofytou
Journal:  JACC Cardiovasc Imaging       Date:  2018-02-14

5.  Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration.

Authors:  M Francesca Cordeiro; Li Guo; Vy Luong; Glen Harding; Wei Wang; Helen E Jones; Stephen E Moss; Adam M Sillito; Frederick W Fitzke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

Review 6.  GLP-1 agonist-based therapies: an emerging new class of antidiabetic drug with potential cardioprotective effects.

Authors:  Melanie Sulistio; Curtis Carothers; Mandeep Mangat; Mike Lujan; Rene Oliveros; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2009-03       Impact factor: 5.113

7.  Ischemic postconditioning: mechanisms, comorbidities, and clinical application.

Authors:  Bruno Buchholz; Martín Donato; Verónica D'Annunzio; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2014-03-13       Impact factor: 3.396

8.  Magnesium Lithospermate B Protects Cardiomyocytes from Ischemic Injury Via Inhibition of TAB1-p38 Apoptosis Signaling.

Authors:  Chang-Sheng Du; Rui-Fang Yang; Shu-Wei Song; Yi-Ping Wang; Jiu-Hong Kang; Ru Zhang; Ding-Feng Su; Xin Xie
Journal:  Front Pharmacol       Date:  2010-08-24       Impact factor: 5.810

9.  An Integrated Approach Based on Network Analysis Combined With Experimental Verification Reveals PI3K/Akt/Nrf2 Signaling Is an Important Way for the Anti-Myocardial Ischemia Activity of Yi-Qi-Tong-Luo Capsule.

Authors:  Huxinyue Duan; Meiyan Li; Jia Liu; Jiayi Sun; Chunjie Wu; Yu Chen; Xiaohui Guo; Xinglong Liu
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

10.  Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation.

Authors:  Lauren Bourke; James McCormick; Valerie Taylor; Charis Pericleous; Benoit Blanchet; Nathalie Costedoat-Chalumeau; Daniel Stuckey; Mark F Lythgoe; Anastasis Stephanou; Yiannis Ioannou
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.